|
Aug 4
|
Xoma strikes deals to buy struggling biotechs HilleVax, Lava
|
|
Aug 4
|
XOMA Royalty Enters into Agreement to Acquire LAVA Therapeutics for Between $1.16 and $1.24 Per Share in Cash, Plus a Contingent Value Right
|
|
Apr 16
|
LAVA Therapeutics Granted Full Waiver for RVO Payment Obligation
|